Take an inside look at Novo Nordisk’s path to open-source for pharma and beyond! @appsilon_official
Take an inside look at Novo Nordisk’s path to open-source for pharma and beyond! @appsilon_official
Uploaded April 2025 | Updated September 2026, 2 weeks ago
In this episode, Ari Siggaard Knoph from Novo Nordisk discusses the company’s transition from SAS to R for FDA submissions. He explains how this shift accelerated innovation, attracted top talent, and redefined clinical programming.

Ari also covers the role of Shiny applications in gaining internal buy-in, how adopting open-source tools broadened the company’s talent pool and improved productivity, and what the future holds for pharmaceutical technology.

Listen to the full episode on your favorite podcasting platform or YouTube!
Take an inside look at Novo Nordisk’s path to open-source for pharma and beyond!Shining Bright: A Recap of R Shiny Insights from posit::conf 2023R Shiny in Life Sciences – Top 7 Dashboard Examples by Ismael RodriguezRoad Mapping in Real-Time: Harnessing R, Python, and Shiny for Dynamic Visualization | ShinyConf2024Tailoring Shiny for Modern Users | ShinyConf 2024Making complex data science work easier means building the right layers of abstractionShiny App Showcase: Lucidum by Gary HemmingShaping the Future of FDA Submissions: Pilot 4s Journey with Containers and WebR | ShinyConf 2024How are pharmaceutical companies navigating the shift to #opensource tools? #SAStoRCase Studies of R Shiny Applications in Higher Education | ShinyConf 2024DepMap Dashboard Exploration - R Shiny AppUnlocking New Technologies With Shiny | ShinyConf 2024
Appsilon |

Take an inside look at Novo Nordisk’s path to open-source for pharma and beyond!

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER